Colleagues to recognize research leadership in cancer detection, prevention and treatment

July 23, 2004

Continuing a 45-year-old tradition of honoring outstanding achievement in cancer research, the American Association for Cancer Research currently is accepting nominations for its series of annual awards. Scientists advancing the understanding and eradication of cancer through basic research, clinical care, therapeutics and prevention are eligible. Winners will help the AACR fulfill its mission to promote professional education and communications by delivering a lecture at the association's 96th Annual Meeting, April 18-20, 2005, in Anaheim, Calif.

Detailed information about each award and the nomination process are available on the AACR Website at www.aacr.org. The fields and corresponding awards represented are:

Basic cancer research:
AACR-G.H.A. Clowes Memorial Award, in honor of a founding member of the AACR and a research director at the Eli Lilly Company

Clinical cancer research:
AACR-Joseph H. Burchenal Clinical Research Award, established by Bristol-Myers Squibb.

Improved clinical cancer care:
AACR-Richard and Hinda Rosenthal Foundation Award, which recognizes notable contributions on the part of medical practitioners aged 50 or younger, and provides incentives to young investigators relatively early in their careers.

Epidemiology, biomarkers and prevention: AACR-American Cancer Society Award for Research Excellence in Epidemiology or Prevention, sponsored jointly by the AACR and the American Cancer Society.

Medicinal chemistry, biochemistry or tumor biology as related to drug discovery: AACR-Bruce F. Cain Memorial Award, established in 1982 by Warner Lambert Company (now Pfizer) to honor Dr. Bruce F. Cain, whose scientific interests involved the design, synthesis and biological evaluation of potential anti-tumor drugs. The award will recognize outstanding contributions in the fields and encompass anticancer, antiviral and antifungal agents.

Nutrition, cancer and cancer prevention: AACR-DeWitt S. Goodman Memorial Lectureship. Supported by anonymous contributions from two AACR members, the award memorializes an international leader in the field of nutrition and cancer.

Advancement of women in science:
AACR-Women in Cancer Research-Charlotte Friend Memorial Lectureship. Named for the renowned virologist and discoverer of the Friend virus, this lecture provides recognition for an outstanding scientist who has made meritorious contributions to the field of cancer research and who has, through leadership or by example, furthered the advancement of women in science.

Since 1961, when the first scientific award was presented, the AACR has honored 172 scientists and physicians, who collectively have made significant contributions to the understanding, diagnosis, prevention and treatment of cancer.
-end-
Founded in 1907, the American Association for Cancer Research is a professional society of more than 22,000 laboratory, translational, and clinical scientists engaged in all areas of cancer research in the United States and in more than 60 other countries. AACR's mission is to accelerate the prevention and cure of cancer through research, education, communication, and advocacy. Its principal activities include the publication of five major peer-reviewed scientific journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. AACR's Annual Meeting attracts more than 15,000 participants who share new and significant discoveries in the cancer field. Specialty meetings, held throughout the year, focus on the latest developments in all areas of cancer research.

American Association for Cancer Research

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.